Carla Haefner,Gerhard Steinmann,Jerry O. Stern,Chan-Loi Yong
申请号：
US12913323
公开号：
US08822496B2
申请日:
2010.10.27
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) an interferon alfa and (c) ribavirin and particular regimens for administering this combination. Compound (1) is a selective and potent inhibitor of the HCV NS3 serine protease. The present invention also relates to methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient.
